Combination of 5α-reductase inhibitor with combined androgen blockade (CAB) as a novel cytoreductive regimen before prostate brachytherapy: Ultra-CAB

We report a first case of using a 5α-reductase inhibitor (5ARI) and combined androgen blockade (CAB) as a cytoreductive regimen before prostate brachytherapy. Prostate volume reduction with CAB is limited to approximately 40% in most cases, making it difficult to meet anatomical constraints to perfo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Clin Exp Urol
Main Authors: Muro, Yusuke, Kosaka, Takeo, Mizuno, Ryuichi, Ohashi, Toshio, Shigematsu, Naoyuki, Oya, Mototsugu
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2015
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4446383/
https://ncbi.nlm.nih.gov/pubmed/26069888
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados